Apollo Financial Statements From 2010 to 2024
| APENDelisted Stock | USD 10.00 0.00 0.00% |
Check Apollo Endosurgery financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Apollo main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Apollo financial statements analysis is a perfect complement when working with Apollo Endosurgery Valuation or Volatility modules.
Apollo |
Apollo Endosurgery Company Current Valuation Analysis
Apollo Endosurgery's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Apollo Endosurgery Current Valuation | 400.85 M |
Most of Apollo Endosurgery's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Apollo Endosurgery is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Apollo Endosurgery has a Current Valuation of 400.85 M. This is 97.21% lower than that of the Health Care Equipment & Supplies sector and 96.77% lower than that of the Health Care industry. The current valuation for all United States stocks is 97.59% higher than that of the company.
Apollo Endosurgery Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Apollo Endosurgery's current stock value. Our valuation model uses many indicators to compare Apollo Endosurgery value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Apollo Endosurgery competition to find correlations between indicators driving Apollo Endosurgery's intrinsic value. More Info.Apollo Endosurgery is number one stock in return on equity category among related companies. It is number one stock in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Apollo Endosurgery by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Apollo Endosurgery's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Apollo Endosurgery's earnings, one of the primary drivers of an investment's value.About Apollo Endosurgery Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Apollo Endosurgery income statement, its balance sheet, and the statement of cash flows. Apollo Endosurgery investors use historical funamental indicators, such as Apollo Endosurgery's revenue or net income, to determine how well the company is positioned to perform in the future. Although Apollo Endosurgery investors may use each financial statement separately, they are all related. The changes in Apollo Endosurgery's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Apollo Endosurgery's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Apollo Endosurgery Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Apollo Endosurgery. Please read more on our technical analysis and fundamental analysis pages.
Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Austin, Texas. Apollo Endosurgery operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 202 people.
Pair Trading with Apollo Endosurgery
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Apollo Endosurgery position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apollo Endosurgery will appreciate offsetting losses from the drop in the long position's value.Moving together with Apollo Stock
| 0.77 | ARTE | Artemis Strategic | PairCorr |
Moving against Apollo Stock
| 0.61 | BA | Boeing Earnings Call Today | PairCorr |
| 0.6 | CSCO | Cisco Systems Fiscal Quarter End 30th of April 2024 | PairCorr |
| 0.51 | TRCA | Twin Ridge Capital | PairCorr |
| 0.51 | T | ATT Inc Earnings Call Today | PairCorr |
The ability to find closely correlated positions to Apollo Endosurgery could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Apollo Endosurgery when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Apollo Endosurgery - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Apollo Endosurgery to buy it.
The correlation of Apollo Endosurgery is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Apollo Endosurgery moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Apollo Endosurgery moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Apollo Endosurgery can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. Note that the Apollo Endosurgery information on this page should be used as a complementary analysis to other Apollo Endosurgery's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Consideration for investing in Apollo Stock
If you are still planning to invest in Apollo Endosurgery check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Apollo Endosurgery's history and understand the potential risks before investing.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |